XCath Advances Robotic Neurointervention to Accelerate Stroke Care
Houston-based XCath is applying surgical robotic technology to catheter intervention, hoping to bring acute stroke interventions to more people than has ever been possible.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueHouston-based XCath is applying surgical robotic technology to catheter intervention, hoping to bring acute stroke interventions to more people than has ever been possible.
With a new orthopedic biomaterial that unites the healing properties of biologics with the strength of load-bearing implants, Orthomod can operate in spine, trauma, cancer-related bone void filling, and other applications.
Five CEOs discuss their companies’ application of AI in medtech to address complex problems in pathology, neurology, cardiology, and clinical research and development.